Marisa Wong Medina

Summary

Affiliation: Children's Hospital Oakland Research Institute
Country: USA

Publications

  1. request reprint
    Medina M. The relationship between HMGCR genetic variation, alternative splicing, and statin efficacy. Discov Med. 2010;9:495-9 pubmed
  2. Medina M, Krauss R. The role of HMGCR alternative splicing in statin efficacy. Trends Cardiovasc Med. 2009;19:173-7 pubmed publisher
  3. Mitchel K, Theusch E, Cubitt C, Dose A, Stevens K, Naidoo D, et al. RP1-13D10.2 Is a Novel Modulator of Statin-Induced Changes in Cholesterol. Circ Cardiovasc Genet. 2016;9:223-30 pubmed publisher
    ..These findings highlight the potential role of noncoding RNAs as determinants of interindividual variation in drug response. ..
  4. Medina M, Theusch E, Naidoo D, Bauzon F, Stevens K, Mangravite L, et al. RHOA is a modulator of the cholesterol-lowering effects of statin. PLoS Genet. 2012;8:e1003058 pubmed publisher
  5. Medina M, Bauzon F, Naidoo D, Theusch E, Stevens K, Schilde J, et al. Transmembrane protein 55B is a novel regulator of cellular cholesterol metabolism. Arterioscler Thromb Vasc Biol. 2014;34:1917-23 pubmed publisher
    ..The findings highlight the value of an integrated genomic approach for identifying genes that influence cholesterol homeostasis. ..
  6. Kim M, Yu C, Theusch E, Naidoo D, Stevens K, Kuang Y, et al. SUGP1 is a novel regulator of cholesterol metabolism. Hum Mol Genet. 2016;25:3106-3116 pubmed
    ..Our results strongly support a role for SUGP1 as a novel regulator of cholesterol metabolism and suggest that it contributes to the relationship between rs10401969 and plasma cholesterol. ..